PureTech Health plc
20-F
April 29, 2026
Key Highlights
- Secured a $500 million deal with Royalty Pharma for the KarXT schizophrenia trea...
- Operates a unique biotech incubator model that spins off independent companies t...
- Strategic focus on Seaport Therapeutics as a primary driver for future growth.
Read Analysis
π€ AI Generated